SightfileU.S. market data from official filings

Companies › EVMN

EVOMMUNE INC (EVMN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002044725 · EDGAR filings · Updated 2026-07-16

EVOMMUNE INC (EVMN) has reported institutional ownership of 96.0%, with 84 institutional managers holding positions valued at $793.4M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
96.0%
Institutional managers
84
Reported 13F value
$793.4M
Insider activity
32 trans.
$70.0M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EVOMMUNE INC has 84 institutional holders and institutional ownership of 96.0%.

Insider activity

Insiders reported 32 transactions (5 buys, 0 sells) across 13 reporting insiders, with a net reported value of $70.0M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-05 (recurring since 2025-12-11) — source filing. The authoritative details are those stated in the filing itself.

Related companies

UROGEN PHARMA LTD (URGN) · JANUX THERAPEUTICS INC (JANX) · THERAVANCE BIOPHARMA INC (TBPH) · PHATHOM PHARMACEUTICALS INC (PHAT) · HARROW INC (HROW) · ARS PHARMACEUTICALS INC (SPRY)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.